Yang H - Search Results

1

Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.

Hu P, Chu GC, Zhu G, Yang H, Luthringer D, Prins G, Habib F, Wang Y, Wang R, Chung LW, Zhau HE. Hu P, et al. Among authors: yang h. PLoS One. 2011;6(12):e28670. doi: 10.1371/journal.pone.0028670. Epub 2011 Dec 21. PLoS One. 2011. PMID: 22205960 Free PMC article.

2

Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study.

Hu P, Chung LW, Berel D, Frierson HF, Yang H, Liu C, Wang R, Li Q, Rogatko A, Zhau HE. Hu P, et al. Among authors: yang h. PLoS One. 2013 Sep 16;8(9):e73081. doi: 10.1371/journal.pone.0073081. eCollection 2013. PLoS One. 2013. PMID: 24066029 Free PMC article.

3

A novel targeting modality to enhance adenoviral replication by vitamin D(3) in androgen-independent human prostate cancer cells and tumors.

Hsieh CL, Yang L, Miao L, Yeung F, Kao C, Yang H, Zhau HE, Chung LW. Hsieh CL, et al. Among authors: yang l, yang h. Cancer Res. 2002 Jun 1;62(11):3084-92. Cancer Res. 2002. PMID: 12036918

4

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.

Kubo H, Gardner TA, Wada Y, Koeneman KS, Gotoh A, Yang L, Kao C, Lim SD, Amin MB, Yang H, Black ME, Matsubara S, Nakagawa M, Gillenwater JY, Zhau HE, Chung LW. Kubo H, et al. Among authors: yang l, yang h. Hum Gene Ther. 2003 Feb 10;14(3):227-41. doi: 10.1089/10430340360535788. Hum Gene Ther. 2003. PMID: 12639303 Clinical Trial.

5

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent.

Qiao J, Li S, Wei L, Jiang J, Long R, Mao H, Wei L, Wang L, Yang H, Grossniklaus HE, Liu ZR, Yang JJ. Qiao J, et al. Among authors: yang jj, yang h. PLoS One. 2011 Mar 24;6(3):e18103. doi: 10.1371/journal.pone.0018103. PLoS One. 2011. PMID: 21455310 Free PMC article.

6

Development of a unique small molecule modulator of CXCR4.

Liang Z, Zhan W, Zhu A, Yoon Y, Lin S, Sasaki M, Klapproth JM, Yang H, Grossniklaus HE, Xu J, Rojas M, Voll RJ, Goodman MM, Arrendale RF, Liu J, Yun CC, Snyder JP, Liotta DC, Shim H. Liang Z, et al. Among authors: yang h. PLoS One. 2012;7(4):e34038. doi: 10.1371/journal.pone.0034038. Epub 2012 Apr 2. PLoS One. 2012. PMID: 22485156 Free PMC article.

7

Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells.

Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA, Cheng JQ. Yang H, et al. Cancer Res. 2004 Jan 15;64(2):463-7. doi: 10.1158/0008-5472.can-03-2907. Cancer Res. 2004. PMID: 14744757

8

The Akt/PKB pathway: molecular target for cancer drug discovery.

Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV. Cheng JQ, et al. Among authors: yang h. Oncogene. 2005 Nov 14;24(50):7482-92. doi: 10.1038/sj.onc.1209088. Oncogene. 2005. PMID: 16288295 Review.

9

Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer.

Kim D, Cheng GZ, Lindsley CW, Yang H, Cheng JQ. Kim D, et al. Among authors: yang h. Curr Opin Investig Drugs. 2005 Dec;6(12):1250-8. Curr Opin Investig Drugs. 2005. PMID: 16370391 Review.

10

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA.

Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ. Kong W, et al. Among authors: yang h. Mol Cell Biol. 2008 Nov;28(22):6773-84. doi: 10.1128/MCB.00941-08. Epub 2008 Sep 15. Mol Cell Biol. 2008. PMID: 18794355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,080 results

Search Page

Filters